AMBICION Co., Ltd.
Company Profile
Company Profile
Message from the CEO
Company Philosophy
Company Profile
Scientific Advisers
Technology
Technology
Natural Killer T (NKT) Cells
NKT cell functions
Mechanisms of NKT cell-targeted cancer immunotherapy
Advantages of NKT cell-targeted cancer immunotherapy
Relationship between RIKEN and AMBICION
Clinical data on NKT cell-targeted cancer immunotherapy
Discovery of a novel ligand “RK” and novel antigen presenting cells (APCs)
Pipelines
Pipelines
RK-pulsed autologous APCs
RK-pulsed allogeneic APCs
News
Published Media
Inquiries
JP
EN
Published Media
Home
Published Media
Please make your inquiries
Inquiries
